ALTIMMUNE, INC. ETF Holding It
ALTIMMUNE, INC. (ALT). 5 retained portfolio positions. Missing dates and values remain unreported.
- AVSU: Fund Avantis Responsible U.S. Equity ETF; Weight 0.00%; Value (USD) $4.14K; Added / first observed 2022-08-31.
- BBC: Fund Virtus Biotech Clinical Trials Etf; Weight 0.36%; Value (USD) $136.17K; Added / first observed 2023-01-31.
- GERM: Fund ETFMG Treatments Testing and Advancements ETF; Weight 1.20%; Value (USD) $153.26K; Added / first observed 2021-12-31.
- IBBJ: Fund Defiance Nasdaq Junior Biotechnology ETF; Weight 0.14%; Value (USD) $10.29K; Added / first observed 2020-12-31.
ETF Holding It
5 retained portfolio positions. Missing dates and values remain unreported.
| ETF | Fund | Weight | Value (USD) | Added / first observed | Latest report |
|---|---|---|---|---|---|
| AVSU | Avantis Responsible U.S. Equity ETF | 0.00% | $4.14K | 2022-08-31 | 2025-05-31 |
| BBC | Virtus Biotech Clinical Trials Etf | 0.36% | $136.17K | 2023-01-31 | 2026-04-30 |
| GERM | ETFMG Treatments Testing and Advancements ETF | 1.20% | $153.26K | 2021-12-31 | 2023-12-31 |
| IBBJ | Defiance Nasdaq Junior Biotechnology ETF | 0.14% | $10.29K | 2020-12-31 | 2021-09-30 |
| IWV | iShares Russell 3000 ETF | 0.00% | $71.34K | 2023-12-31 | 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |